Welcome to the Porton Newsroom
Porton Newsletter - April 2025 Recap
Technical Enabling
Services & Solutions
Company Events
Marketing Activities
Porton Newsletter - Q1 2025 Recap
Technical Enabling
Services & Solutions
Company Events
ESG
Marketing Activities
Porton Newsletter - March 2025 Recap
Technical Enabling
Services & Solutions
Company Events
ESG
Marketing Activities
Porton Newsletter - Jan. to Feb. 2025 Recap
Technical Enabling
Technical Solutions for PROTAC Drugs
Successful GMP Drug Product Delivery by Porton Biologics and Conjugates Platform
Porton Newsletter | Q4 2024 Recap
Porton Expands GMP Manufacturing and New Modality Services in Shanghai Fengxian
Porton Successfully Hosts Ceremony for New Modality Capacity Upgrade
Drug Modalities: Innovative Services & Solutions from Porton Pharma
Porton Newsletter | Q3 2024 Recap
Biologics and Conjugates CDMO Services
Tides CDMO Services
Porton J-STAR Cutting-Edge Technologies
Porton Newsletter | Q2 2024 Recap
Porton Pharma Solutions Embark on The Next Frontier in Mengeš, Slovenia.
Announcement of New GMP HPAPI Lab and Integrated DS-DP Facilities at Porton J-STAR.
Porton can provide one-stop CDMO services from PCC to IND and GMP clinical supply of ADC drugs for global pharmaceutical companies.
Porton Newsletter | Q1 2024 Recap
Porton PharmaTech (Slovenia)-B31 R&D Labs and Kilo lab Suites (non-GMP), expected to be completed in May 2024.
New Facilities Will Be Ready in Porton USA / J-STAR
Porton's Antibody and ADC GMP Pilot Manufactory Officially Operated